口腔癌前病变的纵向研究:恶性瘤的转化率和预测标志物
Duttatrayee Das1, Anu Sumi Issac2, Bhavani N Sangala3
1Department of Oral and Maxillofacial Pathology, Kalinga Institute of Dental Sciences, KIIT Deemed to be University, Patia, Bhubaneswar, Odisha, India.
Journal of pharmacy & bioallied sciences
|September 30, 2024
概括
口腔癌前病变 (OPL) 需要个性化护理. 生物标志物如p53,Ki-67和表皮生长因子受体 (EGFR) 可以预测恶性转变,有助于早期检测口腔癌.
科学领域:
- 口腔医学是指口腔医学.
- 在瘤学瘤学.
- 生物标志物研究 生物标志物研究
背景情况:
- 口腔癌前病变 (OPL) 是口腔癌的重要风险因素.
- 早期发现和管理OPL对于预防恶性转变至关重要.
- 了解OPL转变率和恶性瘤预测指标是有效干预的关键.
研究的目的:
- 评估口腔癌前病变 (OPL) 的转化率.
- 为了确定OPLs恶性瘤的预测性迹象.
- 为了评估与发育不良相关的特定生物标志物的表达.等级.
主要方法:
- 一项纵向研究跟踪了200名临床诊断的OPL患者2年.
- 使用免疫组织化学,组织病理学和临床检查.
- 对生物标志物表达水平 (p53,Ki-67,CDKN2A,EGFR) 进行了分析,以显形性质等级为准.
主要成果:
- 组织病理学检查显示,大多数OPLs呈现轻度发育不良.
- 观察到显著的生物标志物表达:p53 (60.0%),Ki-67 (40.0%),CDKN2A (30.0%),以及表皮生长因子受体 (EGFR) (25.0%).
- 生物标志物表达水平与发育不良的程度相关.
结论:
- 个性化护理计划和例行监测对于OPL患者至关重要.
- EGFR,Ki-67和p53显示出潜在的预后标志物,用于识别恶性转变.
- 需要进一步的研究来验证这些发现,并为高风险患者开发量身定制的治疗方法.
相关概念视频
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
03:18Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K